Search - tctmd.com

Presenter: H. Boden, T.A.N. Ahmed, M.A. Velders, B.L. van der Hoeven, G.E. Hoogslag, M. Bootsma, S. le Cessie, C.M. Cobbaert, A. van der Laarse, M.J. Schalij

January 31, 2013

$Percutaneous, trans-endocardial injection of bone marrow derived mononuclear cells significantly improves left ventricular ejection fraction in patients following acute myocardi...$

Presentation TCT 2013

Percutaneous, trans-endocardial injection of bone marrow derived mononuclear cells significantly improves left ventricular ejection fraction in patients following acute myocardi...

Presenter: Christian Heeger, Cuneo Alessandro, Schneider Carsten, Kai Jaquet, Karl-Heinz Kuck, Bergmann Martin

January 31, 2013

Presentation TCT 2013

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial

Presenter: Benoit Daneault, Philippe Genereux, Ajay Kirtane, Bernhard Witzenbichler, Giulio Guagliumi, Jean-Michel Paradis, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Advertisement

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

Registry Study: Survival Benefit for Treating CTO After Primary PCI

Acute Left Ventricular Unloading and Delayed Coronary Reperfusion Promotes Stromal Cell Derived Factor-1 (SDF-1) Expression and Cardioprotective Signaling in Acute Myocardial___

女性在直接PCI后的左心室功能更差的可能原因是就诊延迟

Worse LV Function After Primary PCI in Women May Be Due to Delay in Presentation

El Empeoramiento de la Función VI tras una PCI Primaria de las Mujeres podría Deberse a Retrasos a la Hora de Acudir al Hospital

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Observational Studies Ask How Much Medication Adherence Matters After MI

La Dominancia Coronaria Influye en el Riesgo Precoz de Mortalidad Post-STEMI

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Bone Marrow Stem Cells Not Effective Early or Late After AMI

The Clinical Utility of High-Sensitive Troponin T to Predict Infarct Size, Left Ventricular Function and Adverse Outcome in Patients with First ST Elevation Myocardial Infarctio...

Percutaneous, trans-endocardial injection of bone marrow derived mononuclear cells significantly improves left ventricular ejection fraction in patients following acute myocardi...

Impact of Left Ventricular Dysfunction and Multi-Vessel Disease After Primary Percutaneous Coronary Intervention: Three-Year Outcomes from the HORIZONS-AMI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content